Digitalis continues to be a commonly prescribed cardiac agent for the treatment
of congestive heart failure and atrial fibrillation. The incidence of severe
digitalis poisonings and adverse effects may be decreasing for a variety of
reasons, but the narrow therapeutic: toxic ratio of digitalis makes toxicity a
continuing problem. The advent of immunotherapy using digoxin-specific antibody
(ovine) ... hiện toàn bộ
Basiliximab (Simulect®) is a recombinant chimeric murine/human IgG1 monoclonal
anti-interleukin-2 receptor antibody that is indicated for the prevention of
acute organ rejection in adult and pediatric renal transplant recipients in
combination with other immunosuppressive agents. Induction therapy with two
doses (day 0 and day 4) of intravenous basiliximab as part of double- or
triple-immunotherap... hiện toàn bộ